Manulife (Manufacturers Life Insurance)
RUBY

Manulife (Manufacturers Life Insurance)’s Rubius Therapeutics, Inc RUBY Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-103,484
Closed -$567K – 3226
2022
Q1 		$567K Buy
103,484
+78,225
+310% +$497K ﹤0.01% 2127
2021
Q4 		$247 Buy
25,259
+287
+1% +$3.98K ﹤0.01% 2760
2021
Q3 		$446K Sell
24,972
-1,516
-6% -$33K ﹤0.01% 2378
2021
Q2 		$647K Buy
26,488
+4,628
+21% +$116K ﹤0.01% 2253
2021
Q1 		$579K Sell
21,860
-3,161
-13% -$46.2K ﹤0.01% 2189
2020
Q4 		$190K Buy
25,021
+973
+4% +$5.78K ﹤0.01% 2799
2020
Q3 		$120K Hold
24,048
– – ﹤0.01% 2742
2020
Q2 		$152K Sell
24,048
-654
-3% -$3.86K ﹤0.01% 2610
2020
Q1 		$110K Buy
24,702
+1,605
+7% +$11.9K ﹤0.01% 2556
2019
Q4 		$219K Sell
23,097
-715
-3% -$6.92K ﹤0.01% 2537
2019
Q3 		$190K Buy
23,812
+734
+3% +$8.55K ﹤0.01% 2618
2019
Q2 		$363K Buy
23,078
+9,573
+71% +$154K ﹤0.01% 2246
2019
Q1 		$244K Buy
+13,505
New +$207K ﹤0.01% 2328

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $293M AUM 36.12% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RUBY Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 103,484 shares — an estimated $567K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RUBY in Q1 2019 and held it in 13 quarters. The position peaked at $647K in Q2 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 103,484 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $567K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Rubius Therapeutics, Inc in Q1 2019 and held it in 13 quarters.
  • Manulife (Manufacturers Life Insurance)'s Rubius Therapeutics, Inc position peaked at $647K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.